6505--Diclofenac Sodium (NA) 1% Gel
ID: 36E79725R0012Type: Presolicitation
Overview

Buyer

VETERANS AFFAIRS, DEPARTMENT OFVETERANS AFFAIRS, DEPARTMENT OFNAC PHARMACEUTICALS (36E797)HINES, IL, 60141, USA

NAICS

Pharmaceutical Preparation Manufacturing (325412)

PSC

DRUGS AND BIOLOGICALS (6505)

Original Source

https://sam.gov/opp/0d55aa66036f46b6b7d4c777a499b4c4/view
Timeline
    Description

    The Department of Veterans Affairs is seeking to procure Diclofenac Sodium (NA) 1% Gel, a pharmaceutical product essential for pain management in patients. This presolicitation opportunity falls under the Pharmaceutical Preparation Manufacturing industry, specifically categorized under the NAICS code 325412 and PSC code 6505, indicating its relevance in the drugs and biologicals sector. The procurement aims to ensure the availability of this critical medication for veterans, highlighting its importance in providing effective treatment options. Interested vendors can reach out to Contract Specialist Ray Roldan at raymond.roldan@va.gov or call 708-786-4930 for further details regarding the solicitation process.

    Point(s) of Contact
    Ray RoldanContract Specialist
    (708) 786-4930
    raymond.roldan@va.gov
    Files
    No associated files provided.
    Lifecycle
    Title
    Type
    6505--Diclofenac Sodium (NA) 1% Gel
    Currently viewing
    Presolicitation
    Similar Opportunities
    6505--Nadolol Tablets
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is soliciting bids for the procurement of Nadolol tablets as part of its Pharmaceutical Prime Vendor Program. This solicitation requires bidders to provide various dosages of Nadolol, along with unique National Drug Codes (NDCs), and to adhere to strict compliance with federal manufacturing practices and regulations, including the Drug Supply Chain Security Act. The consistent supply of these pharmaceuticals is crucial for meeting the healthcare needs of veterans, ensuring they receive necessary medications without interruption. Interested parties should contact Contract Specialist Richard Mahario at Richard.Mahario@va.gov for further details, and must adhere to the submission requirements outlined in the solicitation document, which includes a 0.5% cost recovery fee and specific timelines for bid submission.
    6505--Cyclobenzaprine Tablets (VA-25-00015093)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking qualified contractors to supply Cyclobenzaprine HCL Tablets under solicitation number VA-25-00015093. The procurement involves providing pharmaceutical supplies over a base year and four option years, with specific requirements for submission formats, safety protocols, and compliance with drug supply chain security standards. Cyclobenzaprine is a critical medication used for muscle relaxation, making this procurement essential for ensuring consistent availability for veterans and healthcare facilities. Interested parties should contact Contract Specialist Kenneth Lay at Kenneth.Lay@va.gov for further details regarding the submission process and compliance requirements.
    6505--Baclofen Tablets (VA-25-00026620)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking proposals for the supply of Baclofen tablets through its Pharmaceutical Prime Vendor Program, with the solicitation titled "6505--Baclofen Tablets (VA-25-00026620)." The primary objective of this procurement is to establish a reliable source for various strengths of Baclofen tablets, ensuring consistent availability and quality at pre-negotiated prices, while also requiring compliance with the Drug Supply Chain Security Act and Good Manufacturing Practices as evaluated by the FDA. This contract is crucial for maintaining the supply of necessary pharmaceuticals across VA facilities, addressing issues related to compliance, backorders, and recalls. Interested offerors must submit their bids, including pricing for the base year and four one-year options, along with a 0.5% Cost Recovery Fee, and can direct inquiries to Contracting Officer Adrienne A Albachiara at Adrienne.Albachiara@va.gov.
    6505--762-25-1-040-0496 -Tucson CMOP MESALAMINE -(VA-25-00029547)
    Veterans Affairs, Department Of
    The Department of Veterans Affairs, through its Network Contracting Office 15, is seeking proposals for the procurement of MESALAMINE 375MG SA capsules, specifically requiring 1,200 bottles (120 capsules each) for delivery to the Tucson CMOP facility. This solicitation, numbered 36C77025Q0098, is set aside for small businesses and aims to ensure the timely availability of essential pharmaceuticals for veterans' healthcare needs. Interested vendors must submit their offers, including a signed SF1449 form, a price schedule, proof of state wholesale distributor licensure, and a Buy American Act certificate, by January 21, 2025. Proposals should be directed to Contract Specialist Jennifer Coleman at Jennifer.Coleman4@va.gov, with compliance to the Drug Supply Chain Security Act being a critical requirement for consideration.
    6505--Carbidopa/Levodopa SA Tablet
    Veterans Affairs, Department Of
    The Department of Veterans Affairs is seeking pharmaceutical suppliers to establish a national contract for the provision of Carbidopa/Levodopa SA tablets through its Pharmaceutical Prime Vendor program. The Request for Proposal (RFP) outlines specific requirements for potential contractors, including pricing structures for the base year and four option years, compliance with the Drug Supply Chain Security Act, and the necessity for Good Manufacturing Practices (cGMP) status. This procurement is crucial for ensuring a reliable supply of essential medications for veteran and military healthcare systems across the nation. Interested parties should contact Contract Specialist Christopher Carthron at Christopher.Carthron@va.gov for further details regarding the proposal submission process and deadlines.
    6505--Tamsulosin Capsules
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is issuing a presolicitation notice for Request for Proposal (RFP) 36E79725R0011 concerning the procurement of Tamsulosin Hydrochloride (HCL) Capsules. This procurement aims to ensure an uninterrupted supply of Tamsulosin HCL for the VA, Department of Defense (DoD), Bureau of Prisons (BOP), Indian Health Service (IHS), and other federal healthcare facilities, with one contract awarded to a responsible offeror capable of meeting these needs over a base period of one year, plus four optional one-year extensions. The estimated annual requirements include approximately 1.4 million bottles of 90-count Tamsulosin HCL 0.4mg capsules, along with options for larger packaging sizes, highlighting the importance of consistent medicinal supply for veteran healthcare. Interested vendors should note that the solicitation will be released electronically on or about January 7, 2025, with responses due by January 21, 2025; inquiries can be directed to Contract Specialist Andrew Cazares at Andrew.Cazares@va.gov or (708) 786-4990.
    6505--770_Pharmaceuticals_VA CMOP National Office_36C77025Q0117 770-25-2-0182 - National CMOP T0224 TERBINAFINE HCL 1% CREAM
    Veterans Affairs, Department Of
    The Department of Veterans Affairs (VA) is seeking qualified vendors to fulfill an emergency procurement of Terbinafine HCL 1% Cream for its Consolidated Mail Outpatient Pharmacy (CMOP) facilities across multiple locations. This acquisition, identified by solicitation number 36C77025Q0117, is set aside for small businesses and requires vendors to provide specific documentation, including a completed price schedule in Excel format and a state wholesale distributor license, to ensure compliance with the Drug Supply Chain Security Act. The timely delivery of these pharmaceuticals is crucial for maintaining a reliable supply for veterans, with a delivery timeframe of 10 days after receipt of order and shipments directed to seven designated CMOP locations. Interested vendors must submit their quotes by January 23, 2025, with an estimated award date of January 28, 2025; for further inquiries, contact Michael W. McAlhaney at Michael.McAlhaney@va.gov or (913) 684-0134.
    Dimethyl Fumarate DR Presolicitation
    Dept Of Defense
    The Defense Logistics Agency (DLA) is planning to issue a solicitation for a national requirements contract for Dimethyl Fumarate DR capsules, specifically 120MG capsules in 14 count bottles and 240MG capsules in 60 count bottles. This procurement aims to establish a reliable national supply source for these pharmaceutical products, which are essential for Department of Defense (DoD) customers through the DLA prime vendor program. The contract will be a firm-fixed price, requirements type contract with a one-year base period and four one-year options, emphasizing compliance with federal regulations and efficient distribution of pharmaceuticals for military healthcare. Interested parties should contact Kevin Rafferty at kevin.rafferty@dla.mil or 215-737-0907 for further inquiries, and the projected solicitation date is February 2021, with an amendment extending the offer submission deadline to October 14, 2021, at 3:00 PM EST.
    Valsartan
    Dept Of Defense
    Presolicitation DEPT OF DEFENSE is planning to issue a national requirements contract for Valsartan, a drug used to treat high blood pressure and heart failure. The contract will include Valsartan tablets in various strengths and quantities. It will be a firm-fixed price, requirements type contract with a one year base and four one year options. The contract aims to establish a national supply source for Department of Defense, Department of Veterans Affairs, Indian Health Service, and Bureau of Prisons customers. The solicitation will be posted on the DLA Bid Board System and beta.SAM.gov, with a projected solicitation date in June 2021. Interested parties should contact Christopher Newman for more information.
    Bicalutamide 50MG tablets
    Dept Of Defense
    The Defense Logistics Agency (DLA) is issuing a solicitation for a national requirements contract for Bicalutamide 50MG tablets, available in bottle counts of 30 and 500. The procurement aims to establish a reliable supply source for these pharmaceutical items, which are critical for various Department of Defense and other federal health programs, including the Department of Veterans Affairs and the Indian Health Service. This unrestricted and fully competitive acquisition will be a firm-fixed price contract with a one-year base and four one-year options, with proposals due by January 24, 2025. Interested parties can reach out to Keith Ryales at keith.ryales@dla.mil or 215-737-9199 for further inquiries and are encouraged to monitor the DLA Bid Board System and SAM.gov for updates on the solicitation.